Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 9 de 9
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Cell Rep ; 41(11): 111817, 2022 12 13.
Artículo en Inglés | MEDLINE | ID: mdl-36516756

RESUMEN

During mycobacterial infections, pathogenic mycobacteria manipulate both host immune and stromal cells to establish and maintain a productive infection. In humans, non-human primates, and zebrafish models of infection, pathogenic mycobacteria produce and modify the specialized lipid trehalose 6,6'-dimycolate (TDM) in the bacterial cell envelope to drive host angiogenesis toward the site of forming granulomas, leading to enhanced bacterial growth. Here, we use the zebrafish-Mycobacterium marinum infection model to define the signaling basis of the host angiogenic response. Through intravital imaging and cell-restricted peptide-mediated inhibition, we identify macrophage-specific activation of NFAT signaling as essential to TDM-mediated angiogenesis in vivo. Exposure of cultured human cells to Mycobacterium tuberculosis results in robust induction of VEGFA, which is dependent on a signaling pathway downstream of host TDM detection and culminates in NFATC2 activation. As granuloma-associated angiogenesis is known to serve bacterial-beneficial roles, these findings identify potential host targets to improve tuberculosis disease outcomes.


Asunto(s)
Mycobacterium marinum , Mycobacterium tuberculosis , Tuberculosis , Animales , Humanos , Pez Cebra/microbiología , Macrófagos/metabolismo , Transducción de Señal , Granuloma/patología , Factores de Transcripción NFATC/metabolismo
2.
J Virol ; 96(4): e0203921, 2022 02 23.
Artículo en Inglés | MEDLINE | ID: mdl-34878926

RESUMEN

The single-stranded DNA genome of adeno-associated viruses (AAV) undergoes second-strand synthesis and transcription in the host cell nucleus. While wild-type AAV genomes are naturally silenced upon integration into the host genome, recombinant AAV (rAAV) genomes typically provide robust expression of transgenes persisting as extrachromosomal DNA or episomes. Episomal DNA associating with host histones is subject to epigenetic modifications, although the mechanisms underlying such are not well understood. Here, we provide evidence that the double-stranded DNA binding protein NP220, in association with the human silencing hub (HUSH) complex, mediates transcriptional silencing of single-stranded as well as self-complementary rAAV genomes. In cells lacking NP220 or other components of the HUSH complex, AAV genome transcript levels are increased and correlate with a marked reduction in repressive H3K9 histone methylation marks. We also provide evidence that the AAV capsid (serotype) can profoundly influence NP220-mediated silencing of packaged genomes, indicating potential role(s) for capsid-genome or capsid-host factor interactions in regulating epigenetic silencing of rAAV genomes. IMPORTANCE Recombinant AAV vectors can enable long-term gene expression in a wide variety of tissues. However, transgene silencing has been reported in some human gene therapy clinical trials. Here, we demonstrate the HUSH complex can suppress transcript formation from rAAV vector genomes by epigenetic modification of associated host histones. Further, the AAV capsid appears to play an important role in this pathway. We postulate that modulation of epigenetic pathways could help improve rAAV expression.


Asunto(s)
Proteínas de Unión al ADN/metabolismo , Dependovirus/genética , Silenciador del Gen , Genoma Viral/genética , Complejos Multiproteicos/metabolismo , Proteínas de Unión al ARN/metabolismo , Factores de Transcripción/metabolismo , Antígenos de Neoplasias/genética , Antígenos de Neoplasias/metabolismo , Cápside/metabolismo , Proteínas de Unión al ADN/genética , Dependovirus/metabolismo , Epigénesis Genética , Células HEK293 , Humanos , Complejos Multiproteicos/genética , Proteínas Nucleares/genética , Proteínas Nucleares/metabolismo , Fosfoproteínas/genética , Fosfoproteínas/metabolismo , Proteínas de Unión al ARN/genética , Serogrupo , Factores de Transcripción/genética , Transcripción Genética , Transgenes/genética
3.
J Cell Sci ; 134(8)2021 04 15.
Artículo en Inglés | MEDLINE | ID: mdl-33722979

RESUMEN

CRISPR/Cas9-based tissue-specific knockout techniques are essential for probing the functions of genes in embryonic development and disease using zebrafish. However, the lack of capacity to perform gene-specific rescue or live imaging in the tissue-specific knockout background has limited the utility of this approach. Here, we report a robust and flexible gateway system for tissue-specific gene inactivation in neutrophils. Using a transgenic fish line with neutrophil-restricted expression of Cas9 and ubiquitous expression of single guide (sg)RNAs targeting rac2, specific disruption of the rac2 gene in neutrophils is achieved. Transient expression of sgRNAs targeting rac2 or cdk2 in the neutrophil-restricted Cas9 line also results in significantly decreased cell motility. Re-expressing sgRNA-resistant rac2 or cdk2 genes restores neutrophil motility in the corresponding knockout background. Moreover, active Rac and force-bearing F-actins localize to both the cell front and the contracting tail during neutrophil interstitial migration in an oscillating fashion that is disrupted when rac2 is knocked out. Together, our work provides a potent tool that can be used to advance the utility of zebrafish in identifying and characterizing gene functions in a tissue-specific manner.


Asunto(s)
Neutrófilos , Pez Cebra , Animales , Animales Modificados Genéticamente , Sistemas CRISPR-Cas/genética , Repeticiones Palindrómicas Cortas Agrupadas y Regularmente Espaciadas/genética , Neutrófilos/metabolismo , Pez Cebra/genética , Pez Cebra/metabolismo , Proteínas de Pez Cebra/genética , Proteínas de Pez Cebra/metabolismo , Proteínas de Unión al GTP rac/metabolismo
4.
Elife ; 82019 01 29.
Artículo en Inglés | MEDLINE | ID: mdl-30693866

RESUMEN

Mycobacterium tuberculosis is the leading worldwide cause of death due to a single infectious agent. Existing anti-tuberculous therapies require long treatments and are complicated by multi-drug-resistant strains. Host-directed therapies have been proposed as an orthogonal approach, but few have moved into clinical trials. Here, we use the zebrafish-Mycobacterium marinum infection model as a whole-animal screening platform to identify FDA-approved, host-directed compounds. We identify multiple compounds that modulate host immunity to limit mycobacterial disease, including the inexpensive, safe, and widely used drug clemastine. We find that clemastine alters macrophage calcium transients through potentiation of the purinergic receptor P2RX7. Host-directed drug activity in zebrafish larvae depends on both P2RX7 and inflammasome signaling. Thus, targeted activation of a P2RX7 axis provides a novel strategy for enhanced control of mycobacterial infections. Using a novel explant model, we find that clemastine is also effective within the complex granulomas that are the hallmark of mycobacterial infection.


Asunto(s)
Antituberculosos/farmacología , Clemastina/farmacología , Granuloma/tratamiento farmacológico , Infecciones por Mycobacterium no Tuberculosas/tratamiento farmacológico , Receptores Purinérgicos P2X7/genética , Proteínas de Pez Cebra/genética , Animales , Antialérgicos/farmacología , Calcio/inmunología , Calcio/metabolismo , Modelos Animales de Enfermedad , Reposicionamiento de Medicamentos , Regulación de la Expresión Génica , Granuloma/genética , Granuloma/inmunología , Granuloma/microbiología , Interacciones Huésped-Patógeno/genética , Interacciones Huésped-Patógeno/inmunología , Humanos , Inmunidad Innata/efectos de los fármacos , Inflamasomas , Larva/efectos de los fármacos , Larva/genética , Larva/inmunología , Larva/microbiología , Macrófagos/efectos de los fármacos , Macrófagos/inmunología , Macrófagos/microbiología , Infecciones por Mycobacterium no Tuberculosas/genética , Infecciones por Mycobacterium no Tuberculosas/inmunología , Infecciones por Mycobacterium no Tuberculosas/microbiología , Mycobacterium marinum/crecimiento & desarrollo , Mycobacterium marinum/inmunología , Mycobacterium marinum/patogenicidad , Mycobacterium tuberculosis/patogenicidad , Receptores Purinérgicos P2X7/inmunología , Transducción de Señal , Técnicas de Cultivo de Tejidos , Tuberculosis Pulmonar/tratamiento farmacológico , Tuberculosis Pulmonar/microbiología , Pez Cebra/genética , Pez Cebra/inmunología , Pez Cebra/microbiología , Proteínas de Pez Cebra/agonistas , Proteínas de Pez Cebra/inmunología
5.
Cell Host Microbe ; 24(4): 514-525.e6, 2018 10 10.
Artículo en Inglés | MEDLINE | ID: mdl-30308157

RESUMEN

Mycobacterial infection leads to the formation of characteristic immune aggregates called granulomas, a process accompanied by dramatic remodeling of the host vasculature. As granuloma angiogenesis favors the infecting mycobacteria, it may be actively promoted by bacterial determinants during infection. Using Mycobacterium marinum-infected zebrafish as a model, we identify the enzyme proximal cyclopropane synthase of alpha-mycolates (PcaA) as an important bacterial determinant of granuloma-associated angiogenesis. cis-Cyclopropanation of mycobacterial mycolic acids by pcaA drives the activation of host Vegf signaling within granuloma macrophages. Cyclopropanation of the mycobacterial cell wall glycolipid trehalose dimycolate is both required and sufficient to induce robust host angiogenesis. Inducible genetic inhibition of angiogenesis and Vegf signaling during granuloma formation results in bacterial growth deficits. Together, these data reveal a mechanism by which PcaA-mediated cis-cyclopropanation of mycolic acids promotes bacterial growth and dissemination in vivo by eliciting granuloma vascularization and suggest potential approaches for host-directed therapies.


Asunto(s)
Proteínas Bacterianas/metabolismo , Metiltransferasas/metabolismo , Mycobacterium marinum/enzimología , Neovascularización Patológica/microbiología , Receptores de Factores de Crecimiento Endotelial Vascular/metabolismo , Tuberculoma/microbiología , Inhibidores de la Angiogénesis/farmacología , Animales , Proteínas Bacterianas/genética , Factores Cordón/metabolismo , Modelos Animales de Enfermedad , Humanos , Indazoles , Macrófagos/inmunología , Macrófagos/microbiología , Metiltransferasas/genética , Infecciones por Mycobacterium no Tuberculosas/inmunología , Infecciones por Mycobacterium no Tuberculosas/microbiología , Mycobacterium marinum/genética , Mycobacterium marinum/patogenicidad , Ácidos Micólicos/metabolismo , Neovascularización Patológica/inmunología , Neovascularización Patológica/patología , Pirimidinas/farmacología , Receptores de Factores de Crecimiento Endotelial Vascular/antagonistas & inhibidores , Receptores de Factores de Crecimiento Endotelial Vascular/efectos de los fármacos , Transducción de Señal , Sulfonamidas/farmacología , Tuberculoma/inmunología , Tuberculoma/patología , Pez Cebra
6.
Proc Natl Acad Sci U S A ; 114(37): E7746-E7755, 2017 09 12.
Artículo en Inglés | MEDLINE | ID: mdl-28827342

RESUMEN

Risk, severity, and outcome of infection depend on the interplay of pathogen virulence and host susceptibility. Systematic identification of genetic susceptibility to infection is being undertaken through genome-wide association studies, but how to expeditiously move from genetic differences to functional mechanisms is unclear. Here, we use genetic association of molecular, cellular, and human disease traits and experimental validation to demonstrate that genetic variation affects expression of VAC14, a phosphoinositide-regulating protein, to influence susceptibility to Salmonella enterica serovar Typhi (S Typhi) infection. Decreased VAC14 expression increased plasma membrane cholesterol, facilitating Salmonella docking and invasion. This increased susceptibility at the cellular level manifests as increased susceptibility to typhoid fever in a Vietnamese population. Furthermore, treating zebrafish with a cholesterol-lowering agent, ezetimibe, reduced susceptibility to S Typhi. Thus, coupling multiple genetic association studies with mechanistic dissection revealed how VAC14 regulates Salmonella invasion and typhoid fever susceptibility and may open doors to new prophylactic/therapeutic approaches.


Asunto(s)
Proteínas de la Membrana/genética , Proteínas de la Membrana/metabolismo , Salmonella typhi/genética , Línea Celular Tumoral , Colesterol/genética , Colesterol/metabolismo , Ezetimiba , Variación Genética/genética , Estudio de Asociación del Genoma Completo , Humanos , Péptidos y Proteínas de Señalización Intracelular , Polimorfismo de Nucleótido Simple , Salmonella/genética , Salmonella/patogenicidad , Salmonella typhi/metabolismo , Salmonella typhi/patogenicidad , Fiebre Tifoidea/metabolismo , Fiebre Tifoidea/fisiopatología , Virulencia/genética
7.
PLoS One ; 10(10): e0138949, 2015.
Artículo en Inglés | MEDLINE | ID: mdl-26445458

RESUMEN

Transgenic labeling of innate immune cell lineages within the larval zebrafish allows for real-time, in vivo analyses of microbial pathogenesis within a vertebrate host. To date, labeling of zebrafish macrophages has been relatively limited, with the most specific expression coming from the mpeg1 promoter. However, mpeg1 transcription at both endogenous and transgenic loci becomes attenuated in the presence of intracellular pathogens, including Salmonella typhimurium and Mycobacterium marinum. Here, we describe mfap4 as a macrophage-specific promoter capable of producing transgenic lines in which transgene expression within larval macrophages remains stable throughout several days of infection. Additionally, we have developed a novel macrophage-specific Cre transgenic line under the control of mfap4, enabling macrophage-specific expression using existing floxed transgenic lines. These tools enrich the repertoire of transgenic lines and promoters available for studying zebrafish macrophage dynamics during infection and inflammation and add flexibility to the design of future macrophage-specific transgenic lines.


Asunto(s)
Interacciones Huésped-Patógeno/genética , Macrófagos/microbiología , Infecciones por Mycobacterium/genética , Regiones Promotoras Genéticas/genética , Proteínas de Pez Cebra/genética , Pez Cebra/genética , Pez Cebra/microbiología , Animales , Animales Modificados Genéticamente/genética , Animales Modificados Genéticamente/microbiología , Linaje de la Célula/genética , Modelos Animales de Enfermedad , Inmunidad Innata/genética , Larva/genética , Larva/microbiología , Infecciones por Mycobacterium/microbiología , Mycobacterium marinum/patogenicidad , Salmonella typhimurium/patogenicidad , Transgenes/genética
8.
Nature ; 517(7536): 612-5, 2015 Jan 29.
Artículo en Inglés | MEDLINE | ID: mdl-25470057

RESUMEN

Pathogenic mycobacteria induce the formation of complex cellular aggregates called granulomas that are the hallmark of tuberculosis. Here we examine the development and consequences of vascularization of the tuberculous granuloma in the zebrafish-Mycobacterium marinum infection model, which is characterized by organized granulomas with necrotic cores that bear striking resemblance to those of human tuberculosis. Using intravital microscopy in the transparent larval zebrafish, we show that granuloma formation is intimately associated with angiogenesis. The initiation of angiogenesis in turn coincides with the generation of local hypoxia and transcriptional induction of the canonical pro-angiogenic molecule Vegfaa. Pharmacological inhibition of the Vegf pathway suppresses granuloma-associated angiogenesis, reduces infection burden and limits dissemination. Moreover, anti-angiogenic therapies synergize with the first-line anti-tubercular antibiotic rifampicin, as well as with the antibiotic metronidazole, which targets hypoxic bacterial populations. Our data indicate that mycobacteria induce granuloma-associated angiogenesis, which promotes mycobacterial growth and increases spread of infection to new tissue sites. We propose the use of anti-angiogenic agents, now being used in cancer regimens, as a host-targeting tuberculosis therapy, particularly in extensively drug-resistant disease for which current antibiotic regimens are largely ineffective.


Asunto(s)
Inhibidores de la Angiogénesis/farmacología , Infecciones por Mycobacterium no Tuberculosas/microbiología , Mycobacterium marinum/efectos de los fármacos , Mycobacterium marinum/crecimiento & desarrollo , Neovascularización Patológica/microbiología , Transducción de Señal/efectos de los fármacos , Pez Cebra/microbiología , Inhibidores de la Angiogénesis/uso terapéutico , Animales , Antibióticos Antituberculosos/farmacología , Carga Bacteriana/efectos de los fármacos , Modelos Animales de Enfermedad , Sinergismo Farmacológico , Granuloma/tratamiento farmacológico , Granuloma/metabolismo , Granuloma/microbiología , Granuloma/patología , Hipoxia/metabolismo , Hipoxia/microbiología , Hipoxia/patología , Larva/efectos de los fármacos , Larva/microbiología , Macrófagos/metabolismo , Macrófagos/microbiología , Macrófagos/patología , Infecciones por Mycobacterium no Tuberculosas/tratamiento farmacológico , Infecciones por Mycobacterium no Tuberculosas/metabolismo , Infecciones por Mycobacterium no Tuberculosas/patología , Mycobacterium marinum/patogenicidad , Neovascularización Patológica/tratamiento farmacológico , Receptores de Factores de Crecimiento Endotelial Vascular/antagonistas & inhibidores , Receptores de Factores de Crecimiento Endotelial Vascular/metabolismo , Tuberculosis/tratamiento farmacológico , Tuberculosis/microbiología , Tuberculosis/patología , Factor A de Crecimiento Endotelial Vascular/antagonistas & inhibidores , Factor A de Crecimiento Endotelial Vascular/metabolismo , Pez Cebra/crecimiento & desarrollo
9.
J Colloid Interface Sci ; 345(2): 556-60, 2010 May 15.
Artículo en Inglés | MEDLINE | ID: mdl-20227085

RESUMEN

Low molecular weight organic acids comprise an important pool of reactive ligands in aquatic systems. These acids readily bind to nano-sized mineral particles and thereby strongly influence a particle's physicochemical behavior. Predicting this influence requires the integration of molecular-level details that control surface complexation mechanisms and structures with macro-scale observations of mineral colloid behavior. We report on the aggregation kinetics of nano-sized hematite in the presence of fumaric acid and maleic acid, which are naturally occurring dicarboxylic acids of similar size and structure. Our results indicate that the structure and orientation of the adsorbed dianion at the hematite surface, not the adsorption mechanism, defines the resulting effect. Maleate, which directs both carboxyl groups to the surface in the form of inner- and outer-sphere surface complexes, enhances colloidal stability. Fumarate, however, which binds to the hematite surface as an outer-sphere complex with just one carboxyl group only slightly influenced particle stability. This outcome suggests that subtle differences in the structure of adsorbed acids produce important differences in the physicochemical behavior of particles in dilute aquatic systems.


Asunto(s)
Compuestos Férricos/química , Fumaratos/química , Nanopartículas de Magnetita/química , Maleatos/química , Adsorción , Coloides , Propiedades de Superficie
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...